USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Global Bioanalytical Testing Services, 2021–2027
Acquisition of Disruptive Technologies will be the Key to Driving Growth
23-Aug-2022
North America
Market Research
PD4D-01-00-00-00
HC03578-NA-MT_26838
As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug development activities. Bioanalytical testing is one of the core aspects of drug development. The testing modules include biomarker testing, immunogenicity testing, toxicology, pharmacokinetics (PK), and pharmacodynamics (PD). These modules essentially cover the entire value chain of drug development. Service providers adopt integrated systems and technologies, such as robotic automation, laboratory information management systems (LIMS), advanced mass spectrometry, and bioassays, to facilitate sensitivity and accuracy in the analysis of samples. With the advent of innovative biologics and biosimilars, including novel mRNA therapies, there is a constant requirement for bioanalytical testing services, which continues to provide opportunities to service providers such as full-service CROs, central laboratory vendors, and laboratory research CROs and CDMOs across the globe. In light of growing innovation, there is a strong reliance on fit-for-purpose drug testing and quality-by-design methodologies, which ensure a step-by-step drug development approach, thus increasing success rates and providing pharma/biotech sponsors with a crucial competitive advantage.
This report on global bioanalytical testing services identifies some of the leading growth opportunity areas in terms of customized bioassay and biomarker testing services, highlighting the growing trend of CRO subcontracting to specifically cater to the specialized drug development and accuracy needs. In addition, the market is witnessing a simultaneous adoption of artificial intelligence (AI) and cloud-based LIMS solutions, which work hand in hand with the drug development activities for petabyte-scale data management (genomics/proteomics data sets).
Key Issues Addressed
- How is the bioanalytical testing services market expected to grow through the forecast period?
- What are key trends driving and restricting the outsourcing of bioanalytical testing services?
- What are the regional trends shaping bioanalytical testing services? Which are the high-growth regions?
- What are the key strategies that global stakeholders are adopting to better serve customers while ensuring growth?
- What are the notable investment trends that are helping market players align themselves to industry needs?
- What are the key growth opportunities for CROs, sponsors, and technology participants in the ecosystem?
Author: Aarti Siddhesh Chitale
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Bioanalytical Testing Services
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Market Overview and Segmentation
Key Market Definitions and Segmentation by Type of Testing Services
Bioanalytical Testing Services across Drug Value Chain
Key Trends Analysis by Service Type and Methodology
Growth Drivers
Growth Restraints
Rising Trend of Outsourcing of Bioanalytical Testing
Evolving Vendor Landscape
Evolving Vendor Landscape (continued)
Investment Trends
Increasing Capacity through Facility Expansions
Increasing Capacity Through Facility Expansions (continued)
Increasing Capacity Through Facility Expansions (continued)
Building Bioanalytical Expertise through Acquisitions
Building Bioanalytical Expertise through Acquisitions (continued)
Building Bioanalytical Expertise through Acquisitions (continued)
Partnerships for Technology Access
Key Growth Metrics
Forecast Assumptions
Revenue Forecast—Global
Revenue Forecast Analysis
Revenue Forecast Analysis (continued)
Revenue Share by Type of Testing Services
Revenue Share Analysis by Type of Testing Services
Revenue Share Analysis by Type of Testing Services (continued)
Revenue Share by Large Molecule versus Small Molecules
Revenue Share Analysis by Large Molecule vs. Small Molecules
Revenue Share Analysis by Large Molecule vs. Small Molecules (continued)
Revenue Share by Region
Revenue Share Analysis by Region
Competitive Environment
Key Competitors by Region
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Growth Opportunity 1—Bioanalytical Characterization of mRNA Therapeutics
Growth Opportunity 1—Bioanalytical Characterization of mRNA Therapeutics (continued)
Growth Opportunity 2—Customized Biomarker Assay Development for CGT Testing
Growth Opportunity 2—Customized Biomarker Assay Development for CGT Testing (continued)
Growth Opportunity 3—Sub-contracting to Specialty CROs for Oncology Pipeline
Growth Opportunity 3—Sub-contracting to Specialty CROs for Oncology Pipeline (continued)
Growth Opportunity 4—Cloud-enabled LIMS for DMPK Profiling
Growth Opportunity 4—Cloud-enabled LIMS for DMPK Profiling (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
List of Figures
- Bioanalytical Testing Services: Growth Drivers, Global, 2022 2027
- Bioanalytical Testing Services: Growth Restraints, Global, 2022 2027
- Global Bioanalytical Testing Services: Global, 2021
- Global Bioanalytical Testing Services: Revenue Forecast, Global, 2018 2027
- Global Bioanalytical Testing Services: Revenue Share by Type of Testing Services, Global, 2021
- Global Bioanalytical Testing Services: Revenue Share by Large Molecule vs. Small Molecule, Global, 2021
- Global Bioanalytical Testing Services: Revenue Share by Region, Global, 2021
- Global Bioanalytical Testing Services: Revenue Share of Top Participants, Global, 2021
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interven...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.